Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals Inc


Market Cap$1.97B

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Catalyst Pharmaceuticals IncCatalyst Pharmaceuticals Inc30.30%-5.6-

Current Fair Value

0.8% downside

Overvalued by 0.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.97 Billion
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.56
Outstanding Shares118,115,079
Avg 30 Day Volume1,293,594


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio30.33
Price to Sales5.65
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income0
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Catalyst Pharmaceuticals Inc

CEO: Patrick McEnany